Author： Deshpande Mangesh C. Venkateswarlu Vobalaboina Mantri Arunkumar H. Gadewar Sandeep T.
Publisher： Informa Healthcare
ISSN： 0363-9045
Source： Drug Development and Industrial Pharmacy, Vol.37, Iss.5, 2011-05, pp. : 506-517
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cardiovascular Effects of Glucagon-Like Peptide 1
Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 1, 2011-01 ,pp. :
Access to resources
Recommend
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes
By Bak Ann Mosegaard Egefjord Lærke Gejl Michael Steffensen Charlotte Stecher Chalotte Willemann Smidt Kamille Brock Birgitte Rungby Jørgen
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 10, 2011-10 ,pp. :
Role of glucagon-like peptide-1 analogues on insulin receptor regulation in diabetic rat hearts
By Hantouche Christine M. Bitar Khalil M. Nemer Georges M. Obeid Mounir Y. Kadi Lina N. Der-Boghossian Asdghig H. Bikhazi Anwar B.
Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 1, 2010-01 ,pp. :
By Ribel U. Larsen M.O. Rolin B. Carr R.D. Wilken M. Sturis J. Westergaard L. Deacon C.F. Knudsen L.B.
European Journal of Pharmacology, Vol. 451, Iss. 2, 2002-09 ,pp. :